✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Ishita Drugs & Industries Ltd.

ISHITADR

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹22 Cr.
P/E
22.48

Ishita Drugs & Industries Ltd.

  • Ishita Drugs & Inds.
  • Hamps Bio
  • Adeshwar Meditex

FAQs on Ishita Drugs & Industries Ltd. Shareprice

Ishita Drugs & Inds. has given lower returns compared to its competitors.
Ishita Drugs & Inds. has grown at ~-5.74% over the last 2yrs while peers have grown at a median rate of -4.0%

Ishita Drugs & Inds. is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Ishita Drugs & Inds. is 22.23, while 3 year average PE is 24.74.
Also latest EV/EBITDA of Ishita Drugs & Inds. is 17.19 while 3yr average is 16.8.

View FAQ's On Business

Growth Table

  • Ishita Drugs & Industries Ltd.
  • Hamps Bio
  • Adeshwar Meditex

Balance Sheet

  • Ishita Drugs & Industries Ltd.
  • Hamps Bio
  • Adeshwar Meditex

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Ishita Drugs & Industries Ltd.
  • Hamps Bio
  • Adeshwar Meditex

Cash Flow

  • Ishita Drugs & Industries Ltd.
  • Hamps Bio
  • Adeshwar Meditex

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Ishita Drugs & Industries Ltd.
  • Hamps Bio
  • Adeshwar Meditex

Quarterly Results

  • Ishita Drugs & Industries Ltd.
  • Hamps Bio
  • Adeshwar Meditex

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Ishita Drugs & Industries Ltd. Financials

Balance sheet of Ishita Drugs & Inds. is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Ishita Drugs & Inds. is increasing.
Latest net debt of Ishita Drugs & Inds. is -₹2.73 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹5.6 Crs.

Yes, profit is increasing.
The profit of Ishita Drugs & Inds. is ₹0.97 Crs for TTM, ₹0.87 Crs for Mar 2025 and ₹0.75 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Ishita Drugs & Inds. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech